Eisai Company, Ltd.'s R&D Organization Undergoes "Transformation," Chops 130 Jobs

Published: Dec 02, 2013

Eisai is cutting jobs but others are hiring too! Check it out! (Isn't it tempting?)

Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") announced today that the company's research and development organization, Eisai Product Creation Systems (EPCS), has undergone a transformation with the aim of further focusing and strengthening its product creation capabilities. In order to fulfill its sole mission of ensuring that innovative new drugs that meet unmet medical needs are made available to patients as early as possible, EPCS has flexibly implemented organizational changes deemed necessary according to the progress of Eisai's development pipeline. The changes will allow Eisai to better prioritize and define its product creation activities by creating a leaner organizational structure that will more efficiently drive forward high-priority projects, increase focus on next-generation products and investigational compounds, and enhance the pursuit of innovation during development and discovery.

Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)

Back to news